Dị ka "Drug Administration Law of the People's Republic of China" na "Vaccine Administration Law of the People's Republic of China", iji na-ahazi na-eduzi pharmacovigilance ọrụ nke ọgwụ ike njide na ndị na-achọ ọgwụ na-edebanye aha ọgwụ, State Drug Ọchịchị ahazila ma chepụta “A na-ekwupụtakwa ụkpụrụ nchịkwa nke ọgwụ ọgwụ, yana ekwupụta ihe ndị dị mkpa gbasara mmejuputa iwu njikwa ogo ọgwụ ọgwụ dị ka ndị a:

1. A ga-emejuputa iwu ụkpụrụ njikwa mma na-ahụ maka ọgwụ na Disemba 1, 2021.

2. Ndị na-ejide ikike ịzụ ahịa ọgwụ ọjọọ na ndị na-edebanye aha ọgwụ ga-arụsi ọrụ ike iji kwado maka mmejuputa iwu nke "Pharmacological Vigilance Quality Management Regulations", guzobe ma na-aga n'ihu na-emeziwanye usoro ọgwụ ọgwụ dị ka achọrọ, na ịhazi mmepe nke ọrụ nlekọta ọgwụ.

3. Onye na-ejide ikike ịzụ ahịa ọgwụ ga-emecha ndebanye aha ozi na National Adverse Drug Reaction Monitoring System n'ime ụbọchị 60 site na ụbọchị nke ọkwa a.

4. Ndị ọchịchị na-ahụ maka ọgwụ na mpaghara ga-agba ndị na-ejide ikike ịzụ ahịa ọgwụ na mpaghara nchịkwa ha dị iche iche ka ha kwadosie ike maka mgbasa ozi, mmejuputa iwu na nkọwa dị mkpa, ma na-elekọta ma na-eduzi ikike ịzụ ahịa ọgwụ site n'ịkwalite nyocha oge niile. Onye njide na-emejuputa atumatu "Iwu njikwa ogo ịdịmma nke ọgwụ" dị ka achọrọ, ma na-anakọta ma na-azụghachi okwu na echiche ndị metụtara ya n'oge.

5. National Adverse Drug Reaction Monitoring Center n'otu n'otu na-ahazi ma na-ahazi mgbasa ozi, ọzụzụ na nduzi teknụzụ nke "Pharmacological Vigilance Quality Management Practices", wee mepee kọlụm "Pharmacovigilance Quality Management Practices" na weebụsaịtị gọọmentị iji zaa ajụjụ ndị metụtara ya na echiche n'oge.

Ọkwa pụrụ iche.